Comparison of In Vivo and In Vitro Pharmacodynamics of a Humanized Regimen of 600 Milligrams of Ceftaroline Fosamil Every 12 Hours against Staphylococcus aureus at Initial Inocula of 10(6) and 10(8) CFU per Milliliter

Lignende værker

• Efficacy of Human Simulated Exposures of Ceftaroline Administered at 600 Milligrams Every 12 Hours against Phenotypically Diverse Staphylococcus aureus Isolates
  af: Keel, Rebecca A., et al.
  Udgivet: (2011)
• Summary of the safety and tolerability of two treatment regimens of ceftaroline fosamil: 600 mg every 8 h versus 600 mg every 12 h
  af: Cheng, Karen, et al.
  Udgivet: (2019)
• Efficacy of Ceftaroline Fosamil in a Staphylococcal Murine Pneumonia Model
  af: Bhalodi, Amira A., et al.
  Udgivet: (2012)
• In Vivo Efficacy of Humanized Ceftaroline Fosamil-Avibactam Exposures in a Polymicrobial Infection Model
  af: Bhalodi, Amira A., et al.
  Udgivet: (2013)
• Pharmacokinetic-Pharmacodynamic Analyses for Efficacy of Ceftaroline Fosamil in Patients with Community-Acquired Bacterial Pneumonia
  af: Bhavnani, Sujata M., et al.
  Udgivet: (2013)